RESUMO
Identifying the mechanisms of eukaryotic genome evolution by comparative genomics is often complicated by the multiplicity of events that have taken place throughout the history of individual lineages, leaving only distorted and superimposed traces in the genome of each living organism. The hemiascomycete yeasts, with their compact genomes, similar lifestyle and distinct sexual and physiological properties, provide a unique opportunity to explore such mechanisms. We present here the complete, assembled genome sequences of four yeast species, selected to represent a broad evolutionary range within a single eukaryotic phylum, that after analysis proved to be molecularly as diverse as the entire phylum of chordates. A total of approximately 24,200 novel genes were identified, the translation products of which were classified together with Saccharomyces cerevisiae proteins into about 4,700 families, forming the basis for interspecific comparisons. Analysis of chromosome maps and genome redundancies reveal that the different yeast lineages have evolved through a marked interplay between several distinct molecular mechanisms, including tandem gene repeat formation, segmental duplication, a massive genome duplication and extensive gene loss.
Assuntos
Evolução Molecular , Genes Fúngicos/genética , Genoma Fúngico , Leveduras/classificação , Leveduras/genética , Cromossomos Fúngicos/genética , Sequência Conservada/genética , Duplicação Gênica , Dados de Sequência Molecular , RNA Ribossômico/genética , RNA de Transferência/genética , Proteínas de Saccharomyces cerevisiae/genética , Sintenia/genética , Sequências de Repetição em Tandem/genéticaRESUMO
BACKGROUND: Thoracic surgeons have been incorporating enhanced recovery after surgery (ERAS) protocols into their practices, not only to reduce narcotic usage but also to improve complication rates and decrease lengths of stay. Here, we describe the utility of a regional block technique that can be used for patients undergoing urgent or elective thoracic surgical procedures or suffering from rib fractures. METHODS: We report our initial one-year experience with these erector spinae plane (ESP) blocks. RESULTS: ESP blocks were placed in 42 patients. The procedure was performed by a trained team of anesthesiologists and certified nurse practitioners. It included placement of a catheter on the ipsilateral chest, followed by a 20 ml of 0.2% ropivacaine bolus and continuous infusion. Patients were then followed by the regional team, as long as the catheter was in place. While it had some technical challenges, the block was effective in 83.3% of patients with no reported mortality or major complications. However, given the confounding factors of the study (such as simultaneous implementation of ERAS protocol) and heterogeneity of the patient population, a control group was difficult to ascertain and meaningful opioid consumption analysis was difficult to perform. CONCLUSIONS: Regional blocks, such as the ESP block, complement fundamental ERAS principles and serve as an adjunct to the available armamentarium for non-narcotic ways to control pain in thoracic surgical and chest trauma patients. Continued collaboration between the thoracic surgeons and anesthesiologists is needed for its success.
Assuntos
Anestésicos Locais , Dor Musculoesquelética/terapia , Bloqueio Nervoso/métodos , Manejo da Dor/métodos , Músculos Paraespinais , Ropivacaina , Adulto , Idoso , Idoso de 80 Anos ou mais , Recuperação Pós-Cirúrgica Melhorada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Dor Musculoesquelética/etiologia , Fraturas das Costelas/complicações , Procedimentos Cirúrgicos Torácicos , TóraxRESUMO
Patients in the intensive care unit frequently experience delirium, anxiety, and agitation, with a variety of treatments used. This article discusses the role of an alpha-adrenoceptor agonist, dexmedetomidine, and its clinical relevance and advantages for the agitated patient.
Assuntos
Agonistas alfa-Adrenérgicos/uso terapêutico , Cuidados Críticos/organização & administração , Dexmedetomidina/uso terapêutico , Hipnóticos e Sedativos/uso terapêutico , Agitação Psicomotora/tratamento farmacológico , Doença Aguda , Agonistas alfa-Adrenérgicos/farmacologia , Sedação Consciente/efeitos adversos , Sedação Consciente/métodos , Sedação Consciente/enfermagem , Dexmedetomidina/farmacologia , Monitoramento de Medicamentos/métodos , Monitoramento de Medicamentos/enfermagem , Humanos , Hipnóticos e Sedativos/farmacologia , Locus Cerúleo/anatomia & histologia , Locus Cerúleo/efeitos dos fármacos , Locus Cerúleo/fisiologia , Taxa de Depuração Metabólica , Profissionais de Enfermagem/organização & administração , Papel do Profissional de Enfermagem , Avaliação em Enfermagem , Guias de Prática Clínica como Assunto , Agitação Psicomotora/complicações , Agitação Psicomotora/diagnóstico , Receptores Adrenérgicos alfa 2/efeitos dos fármacos , Receptores Adrenérgicos alfa 2/fisiologia , Distribuição TecidualRESUMO
We have screened the genome of Saccharomyces cerevisiae for fragments that confer a growth-retardation phenotype when overexpressed in a multicopy plasmid with a tetracycline-regulatable (Tet-off) promoter. We selected 714 such fragments with a mean size of 700 base-pairs out of around 84,000 clones tested. These include 493 in-frame open reading frame fragments corresponding to 454 distinct genes (of which 91 are of unknown function), and 162 out-of-frame, antisense and intergenic genomic fragments, representing the largest collection of toxic inserts published so far in yeast.